Voyager Therapeutics: Overview of Clinical Stage Pipeline

Clinical Stage Therapeutic Area

Parkinson Disease

Parkinson disease is a progressive disorder of the nervous system. The disorder affects several regions of the brain, especially an area called the substantia nigra that controls balance and movement.

Treatment Approach: VY-AADC is a gene therapy for Parkinson’s disease that is being developed by Voyager Therapeutics. The treatment is aimed at increasing the patient’s ability to produce dopamine, a signaling molecule that helps regulate movement and emotional responses, which improves motor function. The targeted cells in the central nervous system (CNS) are long-lived, non-dividing neurons, therefore, treatments delivered in a single dose may generate long-lasting, or even lifelong, benefits.

Clinical Stage: Phase 3/Pivitol

Platform: Adeno associated (AAV2) Viral Delivery of Genes into the target cells of the CNS

Comments

Carbohydrate Metabolism: MCQs and answers on Glycolysis & Gluconeogenesis

MCQ on Glycolysis & Gluconeogenesis 1) Which of the following enzyme is not involved in galactose metabolism? a) Glucokinase b) Galactokinase c) Galactose-1-Phosphate Uridyl transferase d) UDP-Galactose 4- epimerase 2) Which of the following enzyme is defective in galactosemia (type I) - a fatal genetic disorder in infants? a) Glucokinase b) Galactokinase c) Galactose-1-Phosphate Uridyl transferase d) UDP-Galactose 4- epimerase 3) In the liver, the accumulation of which of the following metabolite attenuates the inhibitory of ATP on phosphofructokinase? a) Glucose-6-Phosphate b) Citrate c) Fructose-1,6-Bisphosphate d) Fructose-2,6-Bisphosphate 4) Mutation in which of the following enzymes leads to a glycogen storage disease known as "Tarui’s disease"? a) Glucokinase b) Phosphofructokinase c) Phosphoglucomutase d) Pyruvate Kinase 5) E...

Multiple Choice Questions (MCQs) on Diabetes Mellitus: Pathogenesis, Diagnosis and Treatment

MCQs on Diabetes mellitus 1) Diabetes mellitus is a disorder characterized by hyperglycemia. Which of the following is not the common characteristic features of type 2 diabetes mellitus ? a) Impaired insulin secretion b) Increased Insulin resistance c) Diabetic ketoacidosis d) Excessive hepatic glucose production 2) Which of the following are the characteristic features of type 1 diabetes mellitus? a) Type 1 diabetes is caused by an absolute deficiency of insulin. b) Type 1 diabetes is associated with the autoimmune destruction of beta cells. c) Patients with uncontrolled type 1 diabetes present with diabetic ketoacidosis d) All of the above 3) Which of the following serum measurements are not used for the diagnosis of diabetes mellitus? a) Fasting blood glucose d) Postprandial blood glucose c) Insulin ...

MCQs on Neisseria gonorrhoeae and Neisseria meningitidis: Medical microbiology

Multiple Choice Questions on Neisseria species (Gram-negative cocci) 1) A 19-year-old female college freshman, presented to the university health center with a severe headache, fever, and a stiff neck. She lived in a dormitory and was active in various social activities. She had received all her childhood vaccinations but had not received a booster for the meningococcal vaccine recommended before college entry. Clinical Presentation: On day 1, the patient experienced a sudden onset of fever (39.5°C or 103.1°F), severe headache, nausea, and vomiting. She also noticed a rash on her trunk and legs. Over the next two days, her symptoms deteriorated further, leading to photophobia and altered mental status. Concerned, her roommates brought her to the university health center. Physical Examinati...

BIOCHEMISTRY, BIOMEDICINE & PHARMACEUTICS

Search This Blog